Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. EPS 2024–2025
Evommune, Inc. annual/quarterly eps history and growth rate from 2024 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Evommune, Inc. eps for the quarter ending March 31, 2026 was $0.64, a 93.25% decrease year-over-year.
- Evommune, Inc. annual eps for 2025 was $11.22, a 75.23% decrease from 2024.
- Evommune, Inc. annual eps for 2024 was $45.29.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Evommune, Inc. EPS — FAQ
Evommune, Inc. (EVMN) eps over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Evommune, Inc.'s eps?
Evommune, Inc. (EVMN) reported eps of $-11.22 for fiscal 2025.
Where can I see EVMN's eps history?
The chart and table above show Evommune, Inc.'s eps by year and by quarter, including the growth rate.